Cargando…
Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?
Standard pharmacological therapy in Takotsubo syndrome (TTS) is still debated and there is a lack of prospective data. In their recent work in BMC Cardiovascular Disorders Abanador-Kamper et al. found that stroke in TTS has an event rate of 2.8% after 30 days and 4.2% after 12 months and they questi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206855/ https://www.ncbi.nlm.nih.gov/pubmed/30373518 http://dx.doi.org/10.1186/s12872-018-0930-1 |